Cargando…

Selection and Outcome of Portal Vein Resection in Pancreatic Cancer

Pancreatic cancer has the worst prognosis of all gastrointestinal neoplasms. Five-year survival of pancreatic cancer after pancreatectomy is very low, and surgical resection is the only option to cure this dismal disease. The standard surgical procedure is pancreatoduodenectomy (PD) for pancreatic h...

Descripción completa

Detalles Bibliográficos
Autor principal: Nakao, Akimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840455/
https://www.ncbi.nlm.nih.gov/pubmed/24281213
http://dx.doi.org/10.3390/cancers2041990
_version_ 1782478516289273856
author Nakao, Akimasa
author_facet Nakao, Akimasa
author_sort Nakao, Akimasa
collection PubMed
description Pancreatic cancer has the worst prognosis of all gastrointestinal neoplasms. Five-year survival of pancreatic cancer after pancreatectomy is very low, and surgical resection is the only option to cure this dismal disease. The standard surgical procedure is pancreatoduodenectomy (PD) for pancreatic head cancer. The morbidity and especially the mortality of PD have been greatly reduced. Portal vein resection in pancreatic cancer surgery is one attempt to increase resectability and radicality, and the procedure has become safe to perform. Clinicohistopathological studies have shown that the most important indication for portal vein resection in patients with pancreatic cancer is the ability to obtain cancer-free surgical margins. Otherwise, portal vein resection is contraindicated.
format Online
Article
Text
id pubmed-3840455
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-38404552013-11-26 Selection and Outcome of Portal Vein Resection in Pancreatic Cancer Nakao, Akimasa Cancers (Basel) Review Pancreatic cancer has the worst prognosis of all gastrointestinal neoplasms. Five-year survival of pancreatic cancer after pancreatectomy is very low, and surgical resection is the only option to cure this dismal disease. The standard surgical procedure is pancreatoduodenectomy (PD) for pancreatic head cancer. The morbidity and especially the mortality of PD have been greatly reduced. Portal vein resection in pancreatic cancer surgery is one attempt to increase resectability and radicality, and the procedure has become safe to perform. Clinicohistopathological studies have shown that the most important indication for portal vein resection in patients with pancreatic cancer is the ability to obtain cancer-free surgical margins. Otherwise, portal vein resection is contraindicated. MDPI 2010-11-24 /pmc/articles/PMC3840455/ /pubmed/24281213 http://dx.doi.org/10.3390/cancers2041990 Text en © 2010 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Nakao, Akimasa
Selection and Outcome of Portal Vein Resection in Pancreatic Cancer
title Selection and Outcome of Portal Vein Resection in Pancreatic Cancer
title_full Selection and Outcome of Portal Vein Resection in Pancreatic Cancer
title_fullStr Selection and Outcome of Portal Vein Resection in Pancreatic Cancer
title_full_unstemmed Selection and Outcome of Portal Vein Resection in Pancreatic Cancer
title_short Selection and Outcome of Portal Vein Resection in Pancreatic Cancer
title_sort selection and outcome of portal vein resection in pancreatic cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840455/
https://www.ncbi.nlm.nih.gov/pubmed/24281213
http://dx.doi.org/10.3390/cancers2041990
work_keys_str_mv AT nakaoakimasa selectionandoutcomeofportalveinresectioninpancreaticcancer